Recombinant PDCD1 (Spartalizumab Biosimilar) antibody

Catalog No. ABIN7666452

The Human Monoclonal anti-PDCD1 (Spartalizumab Biosimilar) antibody has been validated for . It is suitable to detect PDCD1 (Spartalizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant PDCD1 (Spartalizumab Biosimilar) antibody (ABIN7666452)

Target: PDCD1 (Spartalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This PDCD1 (Spartalizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Product Details anti-PDCD1 (Spartalizumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: PD-1 antibody (Spartalizumab biosimilar)

Purity: ≥95 % (SDS-PAGE&SEC)

Isotype: IgG1

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Storage Comment: Please store the product under the recommended conditions in the the instructions.

Target Details for PDCD1 (Spartalizumab Biosimilar)

Target: PDCD1 (Spartalizumab Biosimilar)

Alternative Name: Spartalizumab biosimilar

Target Type: Biosimilar

Background: Spartalizumab | PDCD1

Gene ID: 5133

UniProt: Q15116